vimarsana.com
Home
Live Updates
Sequana Medical NV: Sequana Medical announces positive top-l
Sequana Medical NV: Sequana Medical announces positive top-l
Sequana Medical NV: Sequana Medical announces positive top-line results from SAHARA Ph. 2a study of DSR 1.0 in diuretic-resistant heart failure patients with persistent congestion and first patient dosed successfully with DSR 2.0 in YUKON
PRESS RELEASEREGULATED INFORMATION - INSIDE INFORMATION15 November 2022, 07:00 am CET Data from SAHARA with first-generation DSR product (DSR 1.0) confirm: Safe, effective and rapid
Related Keywords
Canada ,
China ,
Mexico ,
United States ,
Hong Kong ,
United Kingdom ,
Belgium ,
American ,
Jeffrey Testani ,
Mary Clark ,
Nick Bastin ,
Strategic Communications ,
Professor At Yale University ,
York Heart Association ,
Company Or Sequanamedical ,
Data Monitoring Committee ,
Seattle Heart Failure ,
Jefferies Healthcare Conference ,
Euronext Brussels ,
Direct Sodium Removal ,
Associate Professor ,
Yale University ,
Heart Failure Scientific Advisor ,
Sequana Medical ,
Chief Medical Officer ,
North American ,
Pre Market Approval ,
Investigational New ,
Glomerular Filtration Rate ,
New York Heart Association ,
Seattle Heart Failure Model ,
Safety Monitoring ,
Sequana ,
Medical ,
Nnounces ,
Positive ,
Line ,
Results ,
Rom ,
Sahara ,
Study ,
Diuretic ,
Resistant ,
Heart ,
Failure ,
Patients ,
Persistent ,
Congestion ,
First ,
Patient ,
Hosed ,
Uccessfully ,
Yukon ,